戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 large-effect sizes, 1.0-1.8, equivalent to a total knee replacement).
2 l femoral condyles in 11 patients undergoing total knee replacement.
3 k who had undergone total hip replacement or total knee replacement.
4 and T1rho mapping at 3.0 T before undergoing total knee replacement.
5  and tibial cartilages were harvested during total knee replacement.
6 eoarthritis who were eligible for unilateral total knee replacement.
7 ngioplasty, pancreatic cancer resection, and total knee replacement.
8 esistibile as a cause of infection following total knee replacement.
9 nee tissue obtained from patients undergoing total knee replacement.
10 o (3:1 ratio) either 2 h, 7 d or 21 d before total knee replacement.
11 ease, 889,872 cases of diabetes, and 111,206 total knee replacements.
12  0.6-0.8], RR for patellofemoral vs cemented total knee replacement 0.3 [0.2-0.5], and RR for unicond
13 0.2-0.5], and RR for unicondylar vs cemented total knee replacement 0.5 [0.5-0.6]) were associated wi
14 e replacement (RR for uncemented vs cemented total knee replacement 0.7 [95% CI 0.6-0.8], RR for pate
15                                          For total knee replacement, 10-year implant survival rate wa
16 iscovery set: 313 patients who had undergone total knee replacement, 214 patients who had undergone t
17 ecystectomy [82 372]; hysterectomy [67 452]; total knee replacement [42 313]; breast lumpectomy [18 0
18 uring the study period, 2,275 subjects had a total knee replacement and 825 had a total hip replaceme
19 o the population (venous thromboembolism and total knee replacement) and the interventions compared,
20                            More than 670,000 total knee replacements are performed annually in the Un
21  nonsurgical treatment alone did not undergo total knee replacement before the 12-month follow-up.
22 treatment group, 13 patients (26%) underwent total knee replacement before the 12-month follow-up; in
23 one total hip replacement and 54 276 who had total knee replacement between Jan 1, 1991, and Aug 10,
24 ld female admitted status for post-bilateral total knee replacement complicated by aspiration pneumon
25 , a robust, accurate and automatic, CT-based total knee replacement customisation pipeline was shown
26 es isolated from patients with OA undergoing total knee replacement decreased expression of senescent
27   Patients were randomly assigned to undergo total knee replacement followed by 12 weeks of nonsurgic
28 teral total knee replacement, treatment with total knee replacement followed by nonsurgical treatment
29 rom 17 patients (age 47-75 years) undergoing total knee replacement for OA.
30                                          The total-knee-replacement group had a higher number of seri
31      In the intention-to-treat analysis, the total-knee-replacement group had greater improvement in
32 llowed by 12 weeks of nonsurgical treatment (total-knee-replacement group) or to receive only the 12
33 cement before the 12-month follow-up; in the total-knee-replacement group, 1 patient (2%) received on
34 tomated pipeline capable of designing custom total knee replacement implants from CT scans.
35 deep learning model better predicted risk of total knee replacement in osteoarthritis than did binary
36 patients with knee osteoarthritis undergoing total knee replacement into a proof-of-principle trial.
37 7) were removed from human knee joints after total knee replacement or meniscectomy.
38  targeted procedures (total hip replacement, total knee replacements) or nontargeted procedures (cole
39 periority of carpal tunnel decompression and total knee replacement over non-operative care.
40 in patients who had total hip replacement or total knee replacement over the age of 70 years was abou
41 on of femur fracture, total hip replacement, total knee replacement, partial colectomy, open cholecys
42 tion of deep vein thrombosis in the elective total knee replacement population than combination strat
43 rophylaxis to patients admitted for elective total knee replacement surgery has been proposed as an e
44 mmendations for patients undergoing elective total knee replacement surgery.
45 e obtained from patients undergoing elective total knee replacement surgery.
46 s from 70 osteoarthritis patients undergoing total knee replacement surgery.
47 e prevention of venous thromboembolism after total knee replacement, the efficacy of ximelagatran, an
48 outcomes may be responsible for low rates of total knee replacement (TKR) among African American male
49 g knee radiographs in patients who underwent total knee replacement (TKR) and matched control patient
50 Age- and site-matched controls were taken at total knee replacement (TKR) and varicose vein (VV) oper
51                 Many individuals who undergo total knee replacement (TKR) become long-term opioid use
52 ssociation between diabetes and incidence of total knee replacement (TKR) due to severe KOA in the Si
53  10 people in the United Kingdom will need a total knee replacement (TKR) during their lifetime.
54 ids can help inform appropriate selection of total knee replacement (TKR) for advanced knee osteoarth
55 itation was reported for patients undergoing total knee replacement (TKR) for function (standardized
56     Multidisciplinary prehabilitation before total knee replacement (TKR) for osteoarthritis may impr
57 Medicare beneficiaries who underwent primary total knee replacement (TKR) in 2000.
58 emoral joint space width by at least 2 mm or total knee replacement (TKR) in either knee at followup.
59 sociation between regular metformin use with total knee replacement (TKR) in patients with diabetes.
60 dial knee osteoarthritis can be treated with total knee replacement (TKR) or partial knee replacement
61                 The complicated interplay of total knee replacement (TKR) positioning and patient-spe
62     Little is known about the association of total knee replacement (TKR) removal from the Medicare i
63 ams have been proposed to reduce reliance on total knee replacement (TKR) surgery and improve health
64 ss whether a decision aid improves access to total knee replacement (TKR) surgery for black patients
65 procedures, and perioperative outcomes after total knee replacement (TKR), and to use this informatio
66 rting 15 year or greater survival of primary total knee replacement (TKR), unicondylar knee replaceme
67 ries who need total hip replacement (THR) or total knee replacement (TKR), yet it does not account fo
68 tages, only an invasive option is available: total knee replacement (TKR).
69 mbolism after total hip replacement (THR) or total knee replacement (TKR).
70 f 100 knees of OA patients who were awaiting total knee replacement (TKR).
71 an opportunity to improve outcomes following total knee replacement (TKR).
72                                              Total knee replacements (TKRs) are performed by surgeons
73 notyped in 438 control women, 425 women with total knee replacements (TKRs), and 537 women with total
74 ng trend for more total hip replacements and total knee replacements to be done in the younger patien
75 eoarthritis who were eligible for unilateral total knee replacement, treatment with total knee replac
76 ng the progression of knee osteoarthritis to total knee replacement using MRI scans.
77 ct the progression of knee osteoarthritis to total knee replacement using MRI.
78                                     However, total knee replacement was associated with a higher numb
79 ran, administered starting the morning after total knee replacement, was superior to that of warfarin
80 scertained by total hip replacement [THR] or total knee replacement), were genotyped using highly pol
81 l phenotypes associated with incident OA and total knee replacement, which may aid in stratifying pat
82 iscus/cartilage increased odds of undergoing total knee replacement within 96 months.